Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123685503 | 12368550 | 3 | F | 2010 | 20160726 | 20160513 | 20160804 | EXP | BR-ABBVIE-14P-020-1291163-00 | ABBVIE | 66.03 | YR | F | Y | 75.40000 | KG | 20160804 | MD | BR | BR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123685503 | 12368550 | 1 | PS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | 1 CAPSULE IN THE MORNING, 2 CAPSULES AT LUNCH AND 1 | UNKNOWN,1004749 | 20725 | TID | ||||||||
| 123685503 | 12368550 | 2 | SS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | 2 CAPSULES AT MORNING, 4 AT AFTERNOON, 2 CAPSULES AT DINNER; DAILY DOSE: 8 CAPSULES | UNKNOWN,1004749 | 20725 | TID | ||||||||
| 123685503 | 12368550 | 3 | SS | CREON | PANCRELIPASE AMYLASEPANCRELIPASE LIPASEPANCRELIPASE PROTEASE | 1 | Oral | MORNING/AT LUNCH/NIGHT; 60000UNIT | UNKNOWN,1004749 | 20725 | 20000 | DF | TID | ||||||
| 123685503 | 12368550 | 4 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | IN THE MORNING; AT NIGHT; DAILY DOSE: 2 TABLET | 0 | 1 | DF | BID | |||||||
| 123685503 | 12368550 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 123685503 | 12368550 | 6 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 123685503 | 12368550 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 | ||||||||||||
| 123685503 | 12368550 | 8 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | TWICE A DAY; DAY/NIGHT; DAILY DOSE: 40 MG | 0 | 20 | MG | BID | |||||||
| 123685503 | 12368550 | 9 | C | ENALAPRIL | ENALAPRIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123685503 | 12368550 | 1 | Pancreatitis chronic |
| 123685503 | 12368550 | 4 | Gastric disorder |
| 123685503 | 12368550 | 5 | Dyspepsia |
| 123685503 | 12368550 | 6 | Gastrooesophageal reflux disease |
| 123685503 | 12368550 | 7 | Burning sensation |
| 123685503 | 12368550 | 8 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123685503 | 12368550 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123685503 | 12368550 | Blood pressure increased | |
| 123685503 | 12368550 | Diarrhoea | |
| 123685503 | 12368550 | Drug dose omission | |
| 123685503 | 12368550 | Dyspepsia | |
| 123685503 | 12368550 | Feeling abnormal | |
| 123685503 | 12368550 | Gastrooesophageal reflux disease | |
| 123685503 | 12368550 | Memory impairment | |
| 123685503 | 12368550 | Nausea | |
| 123685503 | 12368550 | Pain | |
| 123685503 | 12368550 | Pancreatic atrophy | |
| 123685503 | 12368550 | Product availability issue | |
| 123685503 | 12368550 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123685503 | 12368550 | 1 | 20071201 | 0 | ||
| 123685503 | 12368550 | 2 | 2015 | 0 | ||
| 123685503 | 12368550 | 3 | 2007 | 2015 | 0 | |
| 123685503 | 12368550 | 4 | 2010 | 0 |